The prior authorization bottleneck is costing patients time they don’t have

Prior authorization in oncology shouldn’t force a tradeoff between oversight and timely patient care. Yet today’s manual, fragmented processes often delay decisions, burden clinicians and staff, and leave patients waiting when time matters most.

There is a better way forward.

In this white paper from ClinicalPath, leaders from provider organizations and health plans—alongside oncology pathway experts—explore how evidence-based pathways can power automated prior authorization. The result: faster decisions, fewer administrative barriers, and uncompromised clinical rigor.

What you’ll learn:

• How to seamlessly embed pathways within EHR workflows

• How standards-based data exchange enables faster approvals for guideline-concordant care

• Which structured data elements (stage, biomarkers, intent, line of therapy) streamline review processes

• How enhanced reporting drives transparency, supports gold-carding, and aligns with value-based care goals

• What’s next: fast-lane models, bundled authorizations, and responsible AI to accelerate approvals

Discover a clear, actionable roadmap to transform oncology prior authorization.

Download the white paper to learn how pathway-driven care can reduce friction across stakeholders and help ensure patients receive timely, guideline-concordant treatment.